Member Info for lse1111

Now up to no 8. Highest position so far.

Does anyone have any information on this?

Now no 9

It's for sale on Amazon for 1st October, though I haven't seen any details on the advertising launch. But you would think it is synchronised.

Now up to 13th

Now up to 14th and 6k sold

Https://www.amazon.com/Best-Sellers-Sexual-Lubricants/zgbs/hpc/10786421

Unfortunately we still have Ingrid.

Office market is not great.

But;

We shouldn’t go into administration.

There wasn’t an equity raise that excluded shareholders.

The open offer lets us buy assets at 10p when the assets are valued at 56p.

Should be the bottom of the market.

Interest rates set to fall, and therefore property prices to rise.

The company will have the money to invest in refurbishment to increase rents, and less requirement for forced sales.

Potential for bid from bottom feeders, post the open offer…could have been a lot worse!

Looks like the asset sales are well advanced so covering the bond is not an issue now. I think that the share issue was a last ditch opportunity to ensure that if sales did not materialise then they had the funds to ensure survival if all else failed. I don’t think it is a realistic option now.

Finished off by saying, "Yesterday Regional also said it would maintain its next quarterly dividend at 1.2p.

At the current share price, that equates to a yield of about 17pc, which is obviously unsustainable. The market is saying that further dividend cuts after the one earlier this year are on the way but brokers have said they believe a divi at or around current levels should be sustainable.

If this is case the shares are severely mispriced and a strong recovery will follow sooner or later. While our portfolio’s paper loss of 72pc in capital terms is clearly unpalatable it would not make any sense to sell at such distressed levels, especially if the income looks reasonably secure. We’ll hold on."

I sent this email to Trinity researchers today;

I was previously a stockbroker, but now just a private investor. I read your excellent research on Futura Medical, of which I am an investor, and I was wondering if you had seen the recent James Barder interview, and whether this might change your DCF model. Specifically in your note, "On the cusp of MED3000 commercialisation Update | 10 November 2022", you write under Valuation and Financials:

....However, pending visibility on the US terms, and given limited disclosure of precise terms in Europe (which includes multiple revenue layers based on various accounting practices) for simplicity we assume Futura Medical receives payments from partners that are equivalent to a royalty rate of 20% on in-market sales.

However on James Barder on Proactive Futura Medical "on track for a profit in 2025 after strong first half" 2 weeks ago when talking about financials about four minutes in says that margins are around 50%.

I was wondering if you would be looking to update your model in light of this information.

Seems to reinforce the resistance around 42p. A flurry of fairly large buys going through.

Let’s hope it’s not dead cat!

50% profit is not too shabby!!!!

Volume up to 500k by 9am. Seems like something may be happening. Volume has really died down recently.

Someone is bullish. Couldn’t buy them thought.

Hi Bandit,

I agree with you. FUM are overpriced on current revenue and sales, but share prices are determined by the future, not the present. Sales in the UK are not going to determine FUM's share price, the US is and the rest of the world are more important, and that is still to come. Going on UK sales it all looks positive!

Excellent video, very positive. Have 25% of the uk market currently. If we get that in US it will be enormous!

*** packed calculatio: well if us is 51% of world market, 2*£64m is nearly £128m. a p/e of 10 would mean a market cap of over £1bn which is 8 or 9 time’s current price. not too shabby!

Be interesting to see how the US takes this announcement. Usually they are very bullish.